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Recent studies confirming the central role which the tissue microenvironment plays 
during tumor formation have lead to increasing interest in epigenetic contributions to 
cancer growth [1]. As these experiments have shown, normal tissues can be induced 
to become cancerous in vivo by altering the ECM structure. Furthermore, stroma 
from healthy adult animals can prevent neoplastic transformation and encourage 
normal growth of grafted epithelial cancer cells. In this context, a physical image of a 
certain cell phenotype captured into a 
biocompatible scaffold may impose cellular 
populations to display a similar phenotype. 
 
Bioimprint is a process capable of permanently 
capturing a replica impression of cells for use in 
high-resolution imaging and analysis [2]. In a step 
towards scaffold formation, we have recently 
modified the original process by replacing the 
previously employed elastomers with a fast UV-
curing, biocompatible, methacrylate copolymer to 
improve replication fidelity [3]. This material 
shows excellent feature replication; however, 
handling is less straightforward than for the 
previously used soft elastomers.  
 
Thus, to enable the repeatable formation of 
biocompatible and potentially geometrically 
bioactive cell imprints, we have developed two 
microfluidic platforms based on active and 
passive pumping [4] for cell-culture and polymer 
delivery. In this paper, we introduce the Bioimprint 
process and the use of the two platforms for the 
culture and replication of Ishikawa endometrial 
cancer cells. The two different setups are shown 
in Fig.1. We will discuss the advantages of using microfluidics for Bioimprint in 
general and of the two different platforms in particular. Both platforms allow for 
controls and experimental cultures to be carried out simultaneously. Similarly, time 
lapse samples can be taken from the same array minimizing variables between cell 
culture sets and thus enabling cell developmental studies. 
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